New Treatments Show Promise for Metastatic HER2-Positive Breast Cancer
Elisa Becze BA, ELS
Voice
Description
Two new drugs in clinical trials are extending survival for women with metastatic HER2-positive breast cancer that had progressed with previous treatment. One of the drugs was effective for brain metastasis, which is particularly difficult to treat. Results from both studies were reported in the New England Journal of Medicine.